As of 2025-12-22, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 1.19 USD. This relative valuation is based on P/E multiples. With the latest stock price at 21.04 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -94.4%.
The range of the Relative Valuation is (34.98) - 43.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.1x | 13.8x |
| Forward P/E multiples | 13.6x - 16.5x | 14.4x |
| Fair Price | (34.98) - 43.69 | 1.19 |
| Upside | -266.2% - 107.7% | -94.4% |
| Date | P/E |
| 2025-12-19 | -8.12 |
| 2025-12-18 | -7.85 |
| 2025-12-17 | -8.16 |
| 2025-12-16 | -8.61 |
| 2025-12-15 | -8.32 |
| 2025-12-12 | -8.31 |
| 2025-12-11 | -8.39 |
| 2025-12-10 | -8.57 |
| 2025-12-09 | -8.56 |
| 2025-12-08 | -8.44 |
| 2025-12-05 | -8.59 |
| 2025-12-04 | -8.81 |
| 2025-12-03 | -8.43 |
| 2025-12-02 | -7.90 |
| 2025-12-01 | -7.61 |
| 2025-11-28 | -8.24 |
| 2025-11-26 | -8.09 |
| 2025-11-25 | -7.47 |
| 2025-11-24 | -7.30 |
| 2025-11-21 | -6.83 |
| 2025-11-20 | -6.36 |
| 2025-11-19 | -6.33 |
| 2025-11-18 | -6.73 |
| 2025-11-17 | -6.77 |
| 2025-11-14 | -7.26 |
| 2025-11-13 | -6.88 |
| 2025-11-12 | -6.95 |
| 2025-11-11 | -6.94 |
| 2025-11-10 | -6.67 |
| 2025-11-07 | -6.80 |
| 2025-11-06 | -6.81 |
| 2025-11-05 | -7.21 |
| 2025-11-04 | -6.25 |
| 2025-11-03 | -9.44 |
| 2025-10-31 | -9.27 |
| 2025-10-30 | -8.97 |
| 2025-10-29 | -9.05 |
| 2025-10-28 | -9.35 |
| 2025-10-27 | -9.07 |
| 2025-10-24 | -8.80 |
| 2025-10-23 | -8.45 |
| 2025-10-22 | -8.67 |
| 2025-10-21 | -9.01 |
| 2025-10-20 | -8.90 |
| 2025-10-17 | -8.69 |
| 2025-10-16 | -9.01 |
| 2025-10-15 | -8.57 |
| 2025-10-14 | -8.27 |
| 2025-10-13 | -8.48 |
| 2025-10-10 | -8.53 |